MARCH 13, 2012

Company

ORAMED PHARMACEUTICALS INC.

Filed

April 13, 2012

Accession Number

0001013594-12-000261

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →